Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar;26(3):306-312.
doi: 10.1016/j.acra.2019.02.003. Epub 2019 Feb 18.

Reprint of: Voxel-Wise Longitudinal Parametric Response Mapping Analysis of Chest Computed Tomography in Smokers

Affiliations

Reprint of: Voxel-Wise Longitudinal Parametric Response Mapping Analysis of Chest Computed Tomography in Smokers

Wassim W Labaki et al. Acad Radiol. 2019 Mar.

Abstract

Rationale and objectives: Chronic obstructive pulmonary disease is a heterogeneous disease characterized by small airway abnormality and emphysema. We hypothesized that a voxel-wise computed tomography analytic approach would identify patterns of disease progression in smokers.

Materials and methods: We analyzed 725 smokers in spirometric GOLD stages 0-4 with two chest CTs 5 years apart. Baseline inspiration, follow-up inspiration and follow-up expiration images were spatially registered to baseline expiration so that each voxel had correspondences across all time points and respiratory phases. Voxel-wise Parametric Response Mapping (PRM) was then generated for the baseline and follow-up scans. PRM classifies lung as normal, functional small airway disease (PRMfSAD), and emphysema (PRMEMPH).

Results: Subjects with low baseline PRMfSAD and PRMEMPH predominantly had an increase in PRMfSAD on follow-up; those with higher baseline PRMfSAD and PRMEMPH mostly had increases in PRMEMPH. For GOLD 0 participants (n = 419), mean 5-year increases in PRMfSAD and PRMEMPH were 0.3% for both; for GOLD 1-4 participants (n = 306), they were 0.6% and 1.6%, respectively. Eighty GOLD 0 subjects (19.1%) had overall radiologic progression (30.0% to PRMfSAD, 52.5% to PRMEMPH, and 17.5% to both); 153 GOLD 1-4 subjects (50.0%) experienced progression (17.6% to PRMfSAD, 48.4% to PRMEMPH, and 34.0% to both). In a multivariable model, both baseline PRMfSAD and PRMEMPH were associated with development of PRMEMPH on follow-up, although this relationship was diminished at higher levels of baseline PRMEMPH.

Conclusion: A voxel-wise longitudinal PRM analytic approach can identify patterns of disease progression in smokers with and without chronic obstructive pulmonary disease.

Keywords: Chronic obstructive pulmonary disease; Computed tomography; Emphysema; Parametric Response Mapping; Small airway disease.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:. Five-year change of chest CT Parametric Response Mapping metrics in GOLD 0 and GOLD 1–4 progressors
The center of each circle represents the mean coordinates % (PRMEMPH and % PRMfSAD) for each type of progression (to fSAD [A], emphysema [B] or both [C]) at the baseline and follow-up visits (identified by the direction of the arrows). The area of each circle is proportional to the number of subjects with a given type of progression (A, B or C) within their GOLD category (0 or 1–4).
Figure 2:
Figure 2:. Illustration of Parametric Response Mapping (PRM) changes on chest CT of a 58-year old man with COPD
(A) Longitudinal PRM changes on representative coronal CT slices showing normal lung parenchyma (green), functional small airway disease [fSAD] (yellow) and emphysema (red). (B) CT slices highlighting individual voxels that were classified as fSAD at baseline and became emphysema 5 years later in that same subject.

Republished from

References

    1. Labaki WW, Martinez CH, Martinez FJ, Galban CJ, Ross BD, Washko GR, Barr RG, Regan EA, Coxson HO, Hoffman EA, Newell JD Jr., Curran-Everett D, Hogg JC, Crapo JD, Lynch DA, Kazerooni EA, Han MK. The Role of Chest Computed Tomography in the Evaluation and Management of the Patient with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2017; 196: 1372–1379. - PMC - PubMed
    1. Galban CJ, Han MK, Boes JL, Chughtai KA, Meyer CR, Johnson TD, Galban S, Rehemtulla A, Kazerooni EA, Martinez FJ, Ross BD. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med 2012; 18: 1711–1715. - PMC - PubMed
    1. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, Curran-Everett D, Silverman EK, Crapo JD. Genetic epidemiology of COPD COPDGene) study design. COPD 2010; 7: 32–43. - PMC - PubMed
    1. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988; 93: 580–586. - PubMed
    1. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321–1327. - PubMed

Publication types